Quanex Building Products Announces Third Quarter 2026 Results
Quanex grew Q3 2026 sales and margins, generated strong free cash flow, reduced leverage, and continued share repurchases while navigating mixed segment trends.
Rhea-AI Summary
Quanex Building Products (NX) reported third quarter 2026 net sales of $501.8 million and diluted EPS of $0.58 for the period ended July 31, 2026.
Net sales rose 1.3% year over year, driven mainly by favorable pricing, partly offset by IEEPA tariff reimbursements to customers. Consolidated gross margin improved to 28.2% from 27.9%, and operating income reached $46.5 million versus a prior-year operating loss largely driven by a $302.3 million non-cash goodwill impairment in 2025. Adjusted net income increased to $36.0 million from $31.6 million, with adjusted diluted EPS up to $0.79 from $0.69 and adjusted EBITDA at $72.7 million, a 14.5% margin.
The Company generated $58.6 million of cash from operating activities and $47.8 million of free cash flow in the quarter, enabling repayment of $42.25 million of debt. Total debt stood at $672.2 million with a Net Debt to LTM Adjusted EBITDA leverage ratio of 2.8x, and liquidity increased 10.5% to $363.1 million. Quanex repurchased 99,786 shares for approximately $1.7 million, leaving $28.7 million under its $75 million authorization.
Positive
- Net sales +1.3% YoY to $501.8 million in Q3 2026
- Gross margin expansion to 28.2% from 27.9% in Q3 2025
- Adjusted diluted EPS rose to $0.79 from $0.69 in Q3 2025
- Adjusted EBITDA increased to $72.7 million with a 14.5% margin in Q3 2026
- Debt reduction of $42.25 million during the quarter; leverage at 2.8x Net Debt/LTM Adjusted EBITDA
- Liquidity up 10.5% to $363.1 million as of July 31, 2026
- Free cash flow improved to $47.8 million from $46.2 million in Q3 2025
Negative
- Hardware Solutions net sales declined 2.7% in Q3 2026 on lower volumes and tariff reimbursements
- Nine-month gross margin decreased to 26.1% from 26.8% year over year
- Nine-month adjusted net income fell to $47.0 million from $68.4 million
- Nine-month adjusted EBITDA declined to $144.3 million from $172.0 million; margin down to 10.5% from 12.8%
- Cash from operations for nine months decreased to $57.3 million from $76.6 million
- Nine-month free cash flow dropped to $24.2 million from $35.6 million
- Total debt remained high at $672.2 million as of July 31, 2026
Key Figures
Previous Earnings Reports
| Date | Event | Sentiment | 24h Move | Catalyst |
|---|---|---|---|---|
| Jun 04 | Q2 earnings report | Negative | -13.4% | Margin compression and lower adjusted EBITDA accompanied modest sales growth. |
| Mar 05 | Q1 earnings report | Negative | -7.7% | Quarterly loss accompanied full-year guidance and elevated seasonal cash needs. |
| Dec 11 | Q4 earnings report | Positive | +9.6% | Acquisition-driven sales growth, debt repayment, and integration synergies highlighted. |
| Sep 04 | Q3 earnings report | Negative | -13.1% | Goodwill impairment produced a substantial net loss despite improved gross margin. |
| Jun 05 | Q2 earnings report | Positive | +10.6% | Sales growth, margin expansion, synergy increases, and debt reduction supported results. |
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
Earnings-tagged events averaged a -2.81% 24-hour move, with the five listed reactions aligned with their reported sentiment.
Key Terms
adjusted ebitda financial
leverage ratio financial
free cash flow financial
AI-generated analysis. How Rhea-AI works. Not financial advice.
Net Sales Growth
Volumes Continue to Track Normal Seasonality Patterns
Margin Expansion Realized in Hardware Solutions Segment and on Consolidated Basis
Continued Progress and Execution on Working Capital Management
HOUSTON, Sept. 03, 2026 (GLOBE NEWSWIRE) -- Quanex Building Products Corporation (NYSE:NX) (“Quanex” or the “Company”) today announced its results for the three months ended July 31, 2026.
The Company reported the following selected financial results:
| Three Months Ended July 31, | Nine Months Ended July 31, | |||||||
| ($ in millions, except per share data) | 2026 | 2025 | 2026 | 2025 | ||||
| Net Sales | ||||||||
| Gross Margin | ||||||||
| Gross Margin % | 28.2% | 27.9% | 26.1% | 26.8% | ||||
| Operating Income (Loss) | ( | ( | ||||||
| Net Income (Loss) | ( | ( | ||||||
| Diluted EPS | ( | ( | ||||||
| Adjusted Net Income | ||||||||
| Adjusted Diluted EPS | ||||||||
| Adjusted EBITDA | ||||||||
| Adjusted EBITDA Margin % | 14.5% | 14.2% | 10.5% | 12.8% | ||||
| Cash Provided By Operating Activities | ||||||||
| Free Cash Flow | ||||||||
(See Non-GAAP Terminology Definitions and Disclaimers section, Non-GAAP Financial Measure Disclosure table, Selected Segment Data table and reconciliation tables for additional information)
George Wilson, Chairman, President and Chief Executive Officer, stated, “Volumes continued to track normal seasonality patterns during the third quarter of 2026, and we made meaningful progress addressing the price versus cost imbalance that impacted our margins in the second quarter of 2026. Inflationary pressures related to macroeconomic concerns and the ongoing conflict in the Middle East are still having an impact, but the initial rate and magnitude of these pressures have somewhat subsided.
“We stayed focused on managing our working capital during the third quarter of 2026, which when coupled with the seasonal uptick in volumes, enabled us to repay
Third Quarter 2026 Results Summary
Quanex reported net sales of
On a consolidated basis, the increase in reported earnings for the third quarter of 2026 compared to the third quarter of 2025 was mainly due to improved pricing, lower depreciation and amortization expense and lower interest expense. Results for the third quarter of 2025 were also impacted by a
Balance Sheet & Liquidity Update
As of July 31, 2026, the Company had total debt of
The Company’s liquidity increased by
Share Repurchases
Quanex’s Board authorized a
Conference Call and Webcast Information
The Company has scheduled a conference call for Friday, September 4, 2026, at 11:00 a.m. ET (10:00 a.m. CT) to discuss the release. A link to the live audio webcast will be available on Quanex’s website at http://www.quanex.com in the Investors section under Presentations & Events.
Participants can pre-register for the conference call using the following link:
https://register-conf.media-server.com/register/BIac7900426be941999342c141e5049229
Registered participants will receive an email containing conference call details for dial-in options. To avoid delays, it is recommended that participants dial into the conference call ten minutes ahead of the scheduled start time. A replay will be available for a limited time on the Company’s website at http://www.quanex.com in the Investors section under Presentations & Events.
About Quanex
Quanex is a global manufacturer with core capabilities and broad applications across various end markets. The Company currently partners with leading OEMs to provide innovative solutions in window, door, solar, refrigeration, custom mixing, building access and cabinetry markets. Looking ahead, Quanex plans to leverage its material science expertise and process engineering to expand into adjacent markets.
Non-GAAP Terminology Definitions and Disclaimers
Adjusted Net Income (defined as net income further adjusted to exclude amortization of step-up for purchase price adjustments on inventory, asset impairment charges, transaction, advisory fees and reorganization costs, restructuring charges related to severance and disposal of software, amortization expense related to intangible assets, pension settlement refund and other net adjustments related to foreign currency transaction gain/loss and effective tax rates reflecting impacts of adjustments on a with and without basis) and Adjusted EPS are non-GAAP financial measures that Quanex believes provide a consistent basis for comparison between periods and more accurately reflect operational performance, as they are not influenced by certain income or expense items not affecting ongoing operations. EBITDA (defined as net income or loss before interest, taxes, depreciation and amortization and other, net), Adjusted EBITDA and LTM Adjusted EBITDA (defined as EBITDA further adjusted to exclude purchase price accounting inventory step-ups, transaction costs, certain severance charges, gain/loss on the sale of certain fixed assets, restructuring charges and asset impairment charges) are non-GAAP financial measures that the Company uses to measure operational performance and assist with financial decision-making. Net Debt is defined as total debt (outstanding balance on the revolving credit facility plus financial lease obligations) less cash and cash equivalents. The leverage ratio of Net Debt to LTM Adjusted EBITDA is a financial measure that the Company believes is useful to investors and financial analysts in evaluating Quanex’s leverage. In addition, with certain limited adjustments, this leverage ratio is the basis for a key covenant in the Company’s credit agreement.
Free Cash Flow is a non-GAAP measure calculated using cash provided by operating activities less capital expenditures. Quanex uses the Free Cash Flow metric to measure operational and cash management performance and assist with financial decision-making. Free Cash Flow is measured before application of certain contractual commitments (including capital lease obligations), and accordingly is not a true measure of the Company’s residual cash flow available for discretionary expenditures. Quanex believes Free Cash Flow is useful to investors in understanding and evaluating the Company’s financial and cash management performance.
Quanex believes that the presented non-GAAP measures provide a consistent basis for comparison between periods and will assist investors in understanding the Company’s financial performance when comparing results to other investment opportunities. These measures allow management and investors to evaluate operational performance and trends without the impact of certain non-cash charges, acquisition-related costs, and other items that may vary significantly from period to period and may not be reflective of Quanex’s core operating results. The presented non-GAAP measures may not be the same as those used by other companies. The Company does not intend for this information to be considered in isolation or as a substitute for other measures prepared in accordance with U.S. GAAP.
Forward Looking Statements
This press release contains “forward-looking statements” within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. Statements that use the words “estimated,” “expect,” “could,” “should,” “believe,” “will,” “might,” “anticipate,” “intend,” “plan,” “project,” “seek,” “would,” “may,” or similar words reflecting future expectations or beliefs are forward-looking statements. The forward-looking statements include, but are not limited to, the following: Quanex’s future operating results, future financial condition, future uses of cash and other expenditures, expenses and tax rates, expectations relating to the Company’s industry, expectations regarding the recovery of price versus cost imbalances, anticipated debt repayment and share repurchase activity, expected operational efficiencies and synergies and the Company’s future growth, including any guidance discussed in this press release. The statements and guidance set forth in this release are based on current expectations. Actual results or events may differ materially from those expressed or implied in these forward-looking statements. Therefore, you should not rely on any of these forward-looking statements. For a complete discussion of factors that may affect the Company’s future performance, please refer to Quanex’s Annual Report on Form 10-K for the fiscal year ended October 31, 2025, and the Company’s Quarterly Reports on Form 10-Q under the sections entitled “Cautionary Note Regarding Forward-Looking Statements” and “Risk Factors”. Any forward-looking statements in this press release are made as of the date hereof, and the Company undertakes no obligation to update or revise any forward-looking statements, whether written or oral, to reflect new information, developments or events.
| CONDENSED CONSOLIDATED STATEMENTS OF INCOME (In thousands, except per share data) (Unaudited) | ||||||||||||||||
| Three Months Ended July 31, | Nine Months Ended July 31, | |||||||||||||||
| 2026 | 2025 | 2026 | 2025 | |||||||||||||
| Net sales | $ | 501,845 | $ | 495,273 | $ | 1,373,301 | $ | 1,347,795 | ||||||||
| Cost of sales | 360,380 | 357,305 | 1,015,517 | 986,129 | ||||||||||||
| Selling, general and administrative | 70,837 | 71,270 | 216,695 | 208,253 | ||||||||||||
| Restructuring charges | - | 1,367 | - | 10,207 | ||||||||||||
| Depreciation and amortization | 24,138 | 33,882 | 73,037 | 77,814 | ||||||||||||
| Asset impairment charges | - | 302,284 | - | 302,284 | ||||||||||||
| Operating income (loss) | 46,490 | (270,835 | ) | 68,052 | (236,892 | ) | ||||||||||
| Interest expense | (11,978 | ) | (14,218 | ) | (36,387 | ) | (42,344 | ) | ||||||||
| Other, net | (93 | ) | 855 | 5,972 | 1,925 | |||||||||||
| Income (loss) before income taxes | 34,419 | (284,198 | ) | 37,637 | (277,311 | ) | ||||||||||
| Income tax (expense) benefit | (7,915 | ) | 8,191 | (11,854 | ) | 6,934 | ||||||||||
| Net income (loss) | $ | 26,504 | $ | (276,007 | ) | $ | 25,783 | $ | (270,377 | ) | ||||||
| Earnings (loss) per common share, basic | $ | 0.58 | $ | (6.04 | ) | $ | 0.57 | $ | (5.83 | ) | ||||||
| Earnings (loss) per common share, diluted | $ | 0.58 | $ | (6.04 | ) | $ | 0.57 | $ | (5.83 | ) | ||||||
| Weighted average common shares outstanding: | ||||||||||||||||
| Basic | 45,461 | 45,691 | 45,466 | 46,395 | ||||||||||||
| Diluted | 45,648 | 45,691 | 45,607 | 46,395 | ||||||||||||
| Cash dividends per share | $ | 0.08 | $ | 0.08 | $ | 0.24 | $ | 0.24 | ||||||||
| QUANEX BUILDING PRODUCTS CORPORATION CONDENSED CONSOLIDATED BALANCE SHEETS (In thousands) (Unaudited) | ||||||||
| July 31, 2026 | October 31, 2025 | |||||||
| ASSETS | ||||||||
| Current assets: | ||||||||
| Cash and cash equivalents | $ | 62,094 | $ | 76,018 | ||||
| Restricted Cash | 2,123 | 2,100 | ||||||
| Accounts receivable, net | 214,768 | 205,384 | ||||||
| Inventories | 276,396 | 254,122 | ||||||
| Income taxes receivable | 5,603 | - | ||||||
| Prepaid assets | 37,452 | 32,387 | ||||||
| Other current assets | 3,847 | 3,764 | ||||||
| Total current assets | 602,283 | 573,775 | ||||||
| Property, plant and equipment, net | 394,021 | 411,591 | ||||||
| Operating lease right-of-use assets | 171,552 | 154,866 | ||||||
| Deferred tax assets | 300 | 2,706 | ||||||
| Goodwill | 273,765 | 271,346 | ||||||
| Intangible assets, net | 522,218 | 549,137 | ||||||
| Other assets | 4,552 | 4,812 | ||||||
| Total assets | $ | 1,968,691 | $ | 1,968,233 | ||||
| LIABILITIES AND STOCKHOLDERS' EQUITY | ||||||||
| Current liabilities: | ||||||||
| Accounts payable | $ | 127,030 | $ | 131,307 | ||||
| Accrued liabilities | 88,209 | 95,155 | ||||||
| Income taxes payable | 9,300 | 12,076 | ||||||
| Current maturities of long-term debt | 26,551 | 27,561 | ||||||
| Current operating lease liabilities | 18,822 | 15,446 | ||||||
| Other liabilities | - | - | ||||||
| Total current liabilities | 269,912 | 281,545 | ||||||
| Long-term debt | 636,814 | 665,268 | ||||||
| Noncurrent operating lease liabilities | 160,290 | 145,459 | ||||||
| Deferred pension benefits | ||||||||
| Deferred income taxes | 137,766 | 135,993 | ||||||
| Liabilities for uncertain tax positions | 1,857 | - | ||||||
| Other liabilities | 16,608 | 13,789 | ||||||
| Total liabilities | 1,223,247 | 1,242,054 | ||||||
| Stockholders’ equity: | ||||||||
| Common stock | 512 | 512 | ||||||
| Additional paid-in-capital | 697,598 | 700,029 | ||||||
| Retained earnings | 179,472 | 164,710 | ||||||
| Accumulated other comprehensive loss | (32,142 | ) | (35,439 | ) | ||||
| Treasury stock at cost | (99,996 | ) | (103,633 | ) | ||||
| Total stockholders’ equity | 745,444 | 726,179 | ||||||
| Total liabilities and stockholders' equity | $ | 1,968,691 | $ | 1,968,233 | ||||
| QUANEX BUILDING PRODUCTS CORPORATION CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOW (In thousands) (Unaudited) | |||||||
| Nine Months Ended July 31, | |||||||
| 2026 | 2025 | ||||||
| Operating activities: | |||||||
| Net (loss) income | $ | 25,783 | $ | (270,377 | ) | ||
| Adjustments to reconcile net loss to cash used for operating activities: | |||||||
| Depreciation and amortization | 73,037 | 77,814 | |||||
| Stock-based compensation | 3,617 | 2,762 | |||||
| Deferred income tax | 664 | (26,440 | ) | ||||
| Goodwill impairment charge | - | 302,284 | |||||
| Other, net | 4,640 | 9,203 | |||||
| Changes in assets and liabilities: | |||||||
| Increase in accounts receivable | (8,685 | ) | (1,727 | ) | |||
| (Increase) decrease in inventory | (21,129 | ) | 5,261 | ||||
| Increase in other current assets | (4,430 | ) | (7,228 | ) | |||
| (Decrease) increase in accounts payable | (2,365 | ) | 144 | ||||
| Decrease in accrued liabilities | (7,601 | ) | (9,725 | ) | |||
| Change in income taxes | (6,629 | ) | (21 | ) | |||
| Other, net | 366 | (5,307 | ) | ||||
| Cash provided by operating activities | 57,268 | 76,643 | |||||
| Investing activities: | |||||||
| Capital expenditures | (33,066 | ) | (40,996 | ) | |||
| Proceeds from disposition of capital assets | 62 | 361 | |||||
| Cash used for investing activities | (33,004 | ) | (40,635 | ) | |||
| Financing activities: | |||||||
| Borrowings under credit facilities | 141,500 | 170,000 | |||||
| Repayments of credit facility borrowings | (164,250 | ) | (213,750 | ) | |||
| Repayments of other long-term debt | (3,316 | ) | (1,962 | ) | |||
| Common stock dividends paid | (10,916 | ) | (11,233 | ) | |||
| Purchase of treasury stock | (1,707 | ) | (29,248 | ) | |||
| Other, net | (704 | ) | (1,186 | ) | |||
| Cash used for financing activities | (39,393 | ) | (87,379 | ) | |||
| Effect of exchange rate changes on cash and cash equivalents | 1,228 | 16,302 | |||||
| Decrease in cash, cash equivalents and restricted cash | (13,901 | ) | (35,069 | ) | |||
| Cash, cash equivalents and restricted cash at beginning of period | 78,118 | 102,995 | |||||
| Cash, cash equivalents and restricted cash at end of period | $ | 64,217 | $ | 67,926 | |||
| QUANEX BUILDING PRODUCTS CORPORATION FREE CASH FLOW AND NET DEBT RECONCILIATION (In thousands) (Unaudited) | |||||||||||||||
| The following table reconciles the Company's calculation of Free Cash Flow, a non-GAAP measure, to its most directly comparable GAAP measure. The Company defines Free Cash Flow as cash provided by operating activities less capital expenditures. | |||||||||||||||
| Three Months Ended July 31, | Nine Months Ended July 31, | ||||||||||||||
| 2026 | 2025 | 2026 | 2025 | ||||||||||||
| Cash provided by operating activities | $ | 58,554 | $ | 60,656 | $ | 57,268 | $ | 76,643 | |||||||
| Capital expenditures | (10,744 | ) | (14,452 | ) | (33,066 | ) | (40,996 | ) | |||||||
| Free Cash Flow | $ | 47,810 | $ | 46,204 | $ | 24,202 | $ | 35,647 | |||||||
| The following table reconciles the Company's Net Debt which is defined as total debt principal of the Company plus finance lease obligations minus cash. | |||||||||||||||
| As of July 31, | |||||||||||||||
| 2026 | 2025 | ||||||||||||||
| Term loan facility | $ | 450,000 | $ | 475,000 | |||||||||||
| Revolving credit facility | 168,500 | 197,500 | |||||||||||||
| Finance lease obligations (1) | 53,697 | 61,194 | |||||||||||||
| Total debt (2) | 672,197 | 733,694 | |||||||||||||
| Less: Cash and cash equivalents | 62,094 | 66,272 | |||||||||||||
| Net Debt | $ | 610,103 | $ | 667,422 | |||||||||||
| (1) Includes | |||||||||||||||
| (2) Excludes outstanding letters of credit. | |||||||||||||||
| QUANEX BUILDING PRODUCTS CORPORATION NON-GAAP FINANCIAL MEASURE DISCLOSURE LAST TWELVE MONTHS ADJUSTED EBITDA RECONCILIATION (In thousands, except per share data) (Unaudited) | ||||||||||||||||||||
| Reconciliation of Last Twelve Months Adjusted EBITDA | Three Months Ended July 31, 2026 | Three Months Ended April 30, 2026 | Three Months Ended January 31, 2026 | Three Months Ended October 31, 2025 | Total | |||||||||||||||
| Reconciliation | Reconciliation | Reconciliation | Reconciliation | Reconciliation | ||||||||||||||||
| Net income (loss) as reported | $ | 26,504 | $ | 3,350 | $ | (4,071 | ) | $ | 19,571 | $ | 45,354 | |||||||||
| Income tax expense (benefit) | 7,915 | 3,766 | 173 | 15,147 | 27,001 | |||||||||||||||
| Other, net | 93 | (448 | ) | (5,617 | ) | (5,246 | ) | (11,218 | ) | |||||||||||
| Interest expense | 11,978 | 12,042 | 12,367 | 13,468 | 49,855 | |||||||||||||||
| Depreciation and amortization | 24,138 | 24,650 | 24,249 | 25,630 | 98,667 | |||||||||||||||
| EBITDA | 70,628 | 43,360 | 27,101 | 68,570 | 209,659 | |||||||||||||||
| Cost of sales (1) | 1,223 | 121 | 407 | 308 | 2,059 | |||||||||||||||
| Selling, general and administrative (1),(2) | 894 | 688 | (126 | ) | 2,040 | 3,496 | ||||||||||||||
| Adjusted EBITDA | $ | 72,745 | $ | 44,169 | $ | 27,382 | $ | 70,918 | $ | 215,214 | ||||||||||
| (1) Severance and other expenses related to manufacturing footprint and performance optimization. | ||||||||||||||||||||
| (2) Transaction, advisory fees, severance and reorganization costs. | ||||||||||||||||||||
| QUANEX BUILDING PRODUCTS CORPORATION NON-GAAP FINANCIAL MEASURE DISCLOSURE (In thousands, except per share data) (Unaudited) | |||||||||||||||||||||||||||||||||
| Reconciliation of Adjusted Net Income and Adjusted EPS | Three Months Ended July 31, 2026 | Three Months Ended July 31, 2025 | Nine Months Ended July 31, 2026 | Nine Months Ended July 31, 2025 | |||||||||||||||||||||||||||||
| Net Income | Diluted EPS | Net Income | Diluted EPS | Net Income | Diluted EPS | Net Income | Diluted EPS | ||||||||||||||||||||||||||
| Net income (loss) as reported | $ | 26,504 | $ | 0.58 | $ | (276,007 | ) | $ | (6.04 | ) | $ | 25,783 | $ | 0.57 | $ | (270,377 | ) | $ | (5.83 | ) | |||||||||||||
| Net income(loss) reconciling items from below | 9,507 | $ | 0.21 | 307,578 | $ | 6.73 | 21,221 | $ | 0.46 | 338,756 | $ | 7.30 | |||||||||||||||||||||
| Adjusted net income and adjusted EPS | $ | 36,011 | $ | 0.79 | $ | 31,571 | $ | 0.69 | $ | 47,004 | $ | 1.03 | $ | 68,379 | $ | 1.47 | |||||||||||||||||
| Reconciliation of Adjusted EBITDA | Three Months Ended July 31, 2026 | Three Months Ended July 31, 2025 | Nine Months Ended July 31, 2026 | Nine Months Ended July 31, 2025 | |||||||||||||||||||||||||||||
| Reconciliation | Reconciliation | Reconciliation | Reconciliation | ||||||||||||||||||||||||||||||
| Net income (loss) as reported | $ | 26,504 | $ | (276,007 | ) | $ | 25,783 | $ | (270,377 | ) | |||||||||||||||||||||||
| Income tax expense | 7,915 | (8,191 | ) | 11,854 | (6,934 | ) | |||||||||||||||||||||||||||
| Other, net | 93 | (855 | ) | (5,972 | ) | (1,925 | ) | ||||||||||||||||||||||||||
| Interest expense | 11,978 | 14,218 | 36,387 | 42,344 | |||||||||||||||||||||||||||||
| Depreciation and amortization | 24,138 | 33,882 | 73,037 | 77,814 | |||||||||||||||||||||||||||||
| Asset impairment charges | - | 302,284 | - | 302,284 | |||||||||||||||||||||||||||||
| EBITDA | 70,628 | 65,331 | 141,089 | 143,206 | |||||||||||||||||||||||||||||
| EBITDA reconciling items from below | 2,117 | 4,964 | 3,207 | 28,766 | |||||||||||||||||||||||||||||
| Adjusted EBITDA | $ | 72,745 | $ | 70,295 | $ | 144,296 | $ | 171,972 | |||||||||||||||||||||||||
| Reconciling Items | Three Months Ended July 31, 2026 | Three Months Ended July 31, 2025 | Nine Months Ended July 31, 2026 | Nine Months Ended July 31, 2025 | |||||||||||||||||||||||||||||
| Income Statement | Reconciling Items | Income Statement | Reconciling Items | Income Statement | Reconciling Items | Income Statement | Reconciling Items | ||||||||||||||||||||||||||
| Net sales | $ | 501,845 | $ | - | $ | 495,273 | $ | - | $ | 1,373,301 | $ | - | $ | 1,347,795 | $ | - | |||||||||||||||||
| Cost of sales | 360,380 | (1,223 | ) | (1) | 357,305 | (148 | ) | (1) | 1,015,517 | (1,751 | ) | (1) | 986,129 | (1,124 | ) | (1) | |||||||||||||||||
| Selling, general and administrative | 70,837 | (894 | ) | (1),(3) | 71,270 | (3,449 | ) | (1),(3) | 216,695 | (1,456 | ) | (1),(3) | 208,253 | (17,435 | ) | (1),(2),(3) | |||||||||||||||||
| Restructuring charges | - | - | 1,367 | (1,367 | ) | (4) | - | - | 10,207 | (10,207 | ) | (4) | |||||||||||||||||||||
| EBITDA | 70,628 | 2,117 | 65,331 | 4,964 | 141,089 | 3,207 | 143,206 | 28,766 | |||||||||||||||||||||||||
| Asset impairment charges | - | - | 302,284 | (302,284 | ) | (5) | - | - | 302,284 | (302,284 | ) | (5) | |||||||||||||||||||||
| Depreciation and amortization | 24,138 | (9,758 | ) | (6) | 33,882 | (19,604 | ) | (6) | 73,037 | (29,291 | ) | (6) | 77,814 | (36,708 | ) | (6) | |||||||||||||||||
| Operating income (loss) | 46,490 | 11,875 | (270,835 | ) | 326,852 | 68,052 | 32,498 | (236,892 | ) | 367,758 | |||||||||||||||||||||||
| Interest expense | (11,978 | ) | - | (14,218 | ) | - | (36,387 | ) | - | (42,344 | ) | - | |||||||||||||||||||||
| Other, net | (93 | ) | 288 | (7) | 855 | (949 | ) | (7) | 5,972 | (4,942 | ) | (7) | 1,925 | (118 | ) | (7) | |||||||||||||||||
| Income (loss) before income taxes | 34,419 | 12,163 | (284,198 | ) | 325,903 | 37,637 | 27,556 | (277,311 | ) | 367,640 | |||||||||||||||||||||||
| Income tax (expense) benefit | (7,915 | ) | (2,656 | ) | (8) | 8,191 | (18,325 | ) | (8) | (11,854 | ) | (6,335 | ) | (8) | 6,934 | (28,884 | ) | (8) | |||||||||||||||
| Net income (loss) | $ | 26,504 | 9,507 | $ | (276,007 | ) | $ | 307,578 | $ | 25,783 | 21,221 | $ | (270,377 | ) | $ | 338,756 | |||||||||||||||||
| Diluted earnings (loss) per share | $ | 0.58 | $ | (6.04 | ) | $ | 0.57 | $ | (5.83 | ) | |||||||||||||||||||||||
| (1) Severance and other expenses related to manufacturing footprint and performance optimization. | |||||||||||||||||||||||||||||||||
| (2) Amortization of step-up for purchase price adjustments on inventory. | |||||||||||||||||||||||||||||||||
| (3) Transaction, advisory fees, and severance and reorganization costs. | |||||||||||||||||||||||||||||||||
| (4) Restructuring charges related to severance and disposal of software. | |||||||||||||||||||||||||||||||||
| (5) Goodwill impairment. | |||||||||||||||||||||||||||||||||
| (6) Amortization expense related to intangible assets. | |||||||||||||||||||||||||||||||||
| (7) Foreign currency transaction (gains) losses. | |||||||||||||||||||||||||||||||||
| (8) Tax impact of net income reconciling items. | |||||||||||||||||||||||||||||||||
| QUANEX BUILDING PRODUCTS CORPORATION SELECTED SEGMENT DATA (In thousands) (Unaudited) | ||||||||||||||||||||
| This table provides gross margin, operating income (loss), EBITDA, and Adjusted EBITDA by reportable segment. Non-operating expense and income tax expense are not allocated to the reportable segments. | ||||||||||||||||||||
| Hardware Solutions | Extruded Solutions | Custom Solutions | Unallocated Corp & Other | Total | ||||||||||||||||
| Three months ended July 31, 2026 | ||||||||||||||||||||
| Net sales | $ | 220,923 | $ | 179,291 | $ | 111,007 | $ | (9,376 | ) | $ | 501,845 | |||||||||
| Cost of sales | 162,056 | 121,389 | 85,861 | (8,926 | ) | 360,380 | ||||||||||||||
| Gross Margin | 58,867 | 57,902 | 25,146 | (450 | ) | 141,465 | ||||||||||||||
| Gross Margin % | 26.6 | % | 32.3 | % | 22.7 | % | 28.2 | % | ||||||||||||
| Selling, general and administrative (1) | 33,162 | 22,279 | 13,143 | 2,253 | 70,837 | |||||||||||||||
| Depreciation and amortization | 11,386 | 7,213 | 5,330 | 209 | 24,138 | |||||||||||||||
| Operating (loss) income | 14,319 | 28,410 | 6,673 | (2,912 | ) | 46,490 | ||||||||||||||
| Depreciation and amortization | 11,386 | 7,213 | 5,330 | 209 | 24,138 | |||||||||||||||
| EBITDA | 25,705 | 35,623 | 12,003 | (2,703 | ) | 70,628 | ||||||||||||||
| Expense related to plant relocation and closure (Cost of sales) | 1,223 | - | - | - | 1,223 | |||||||||||||||
| Reorganization and severance costs | 127 | 1 | - | 766 | 894 | |||||||||||||||
| Adjusted EBITDA | $ | 27,055 | $ | 35,624 | $ | 12,003 | $ | (1,937 | ) | $ | 72,745 | |||||||||
| Adjusted EBITDA Margin % | 12.2 | % | 19.9 | % | 10.8 | % | 14.5 | % | ||||||||||||
| Three months ended July 31, 2025 | ||||||||||||||||||||
| Net sales | $ | 227,116 | $ | 174,427 | $ | 102,264 | $ | (8,534 | ) | $ | 495,273 | |||||||||
| Cost of sales | 170,282 | 116,597 | 77,755 | (7,329 | ) | 357,305 | ||||||||||||||
| Gross Margin | 56,834 | 57,830 | 24,509 | (1,205 | ) | 137,968 | ||||||||||||||
| Gross Margin % | 25.0 | % | 33.2 | % | 24.0 | % | 27.9 | % | ||||||||||||
| Selling, general and administrative (1) | 32,954 | 20,740 | 11,708 | 5,868 | 71,270 | |||||||||||||||
| Restructuring charges | 1,140 | 34 | 26 | 167 | 1,367 | |||||||||||||||
| Depreciation and amortization | 16,987 | 6,989 | 4,716 | 5,190 | 33,882 | |||||||||||||||
| Asset impairment charges | 163,198 | 54,934 | 84,152 | - | 302,284 | |||||||||||||||
| Operating income (loss) | (157,445 | ) | (24,867 | ) | (76,093 | ) | (12,430 | ) | (270,835 | ) | ||||||||||
| Depreciation and amortization | 16,987 | 6,989 | 4,716 | 5,190 | 33,882 | |||||||||||||||
| Asset impairment charges | 163,198 | 54,934 | 84,152 | - | 302,284 | |||||||||||||||
| EBITDA | 22,740 | 37,056 | 12,775 | (7,240 | ) | 65,331 | ||||||||||||||
| Expense related to plant relocation and closure (Cost of sales) | 148 | - | - | - | 148 | |||||||||||||||
| Transaction, advisory fees, reorganization costs, and product recall expenses | 715 | - | 50 | 2,684 | 3,449 | |||||||||||||||
| Restructuring charges | 1,140 | 34 | 26 | 167 | 1,367 | |||||||||||||||
| Adjusted EBITDA | $ | 24,743 | $ | 37,090 | $ | 12,851 | $ | (4,389 | ) | $ | 70,295 | |||||||||
| Adjusted EBITDA Margin % | 10.9 | % | 21.3 | % | 12.6 | % | 14.2 | % | ||||||||||||
| Nine months ended July 31, 2026 | ||||||||||||||||||||
| Net sales | $ | 613,054 | $ | 484,040 | $ | 304,062 | $ | (27,855 | ) | $ | 1,373,301 | |||||||||
| Cost of sales | 475,172 | 331,979 | 236,302 | (27,936 | ) | 1,015,517 | ||||||||||||||
| Gross Margin | 137,882 | 152,061 | 67,760 | 81 | 357,784 | |||||||||||||||
| Gross Margin % | 22.5 | % | 31.4 | % | 22.3 | % | 26.1 | % | ||||||||||||
| Selling, general and administrative (1) | 103,105 | 65,084 | 40,182 | 8,324 | 216,695 | |||||||||||||||
| Depreciation and amortization | 34,626 | 21,893 | 15,956 | 562 | 73,037 | |||||||||||||||
| Operating (loss) income | 151 | 65,084 | 11,622 | (8,805 | ) | 68,052 | ||||||||||||||
| Depreciation and amortization | 34,626 | 21,893 | 15,956 | 562 | 73,037 | |||||||||||||||
| EBITDA | 34,777 | 86,977 | 27,578 | (8,243 | ) | 141,089 | ||||||||||||||
| Expense related to plant relocation and closure (Cost of sales) | 1,751 | - | - | - | 1,751 | |||||||||||||||
| Credit related to plant relocation (SG&A) | (8 | ) | - | - | - | (8 | ) | |||||||||||||
| Reorganization and severance costs | 273 | 1 | 1 | 1,189 | 1,464 | |||||||||||||||
| Adjusted EBITDA | $ | 36,793 | $ | 86,978 | $ | 27,579 | $ | (7,054 | ) | $ | 144,296 | |||||||||
| Adjusted EBITDA Margin % | 6.0 | % | 18.0 | % | 9.1 | % | 10.5 | % | ||||||||||||
| Nine months ended July 31, 2025 | ||||||||||||||||||||
| Net sales | $ | 614,791 | $ | 478,024 | $ | 284,809 | $ | (29,829 | ) | $ | 1,347,795 | |||||||||
| Cost of sales | 466,600 | 325,914 | 219,755 | (26,140 | ) | 986,129 | ||||||||||||||
| Gross Margin | 148,191 | 152,110 | 65,054 | (3,689 | ) | 361,666 | ||||||||||||||
| Gross Margin % | 24.1 | % | 31.8 | % | 22.8 | % | 26.8 | % | ||||||||||||
| Selling, general and administrative (1) | 98,570 | 60,921 | 34,156 | 14,606 | 208,253 | |||||||||||||||
| Restructuring charges | 8,155 | 34 | 26 | 1,992 | 10,207 | |||||||||||||||
| Depreciation and amortization | 38,818 | 22,066 | 15,693 | 1,237 | 77,814 | |||||||||||||||
| Asset impairment charges | 163,198 | 54,934 | 84,152 | - | 302,284 | |||||||||||||||
| Operating (loss) income | (160,550 | ) | 14,155 | (68,973 | ) | (21,524 | ) | (236,892 | ) | |||||||||||
| Depreciation and amortization | 38,818 | 22,066 | 15,693 | 1,237 | 77,814 | |||||||||||||||
| Asset impairment charges | 163,198 | 54,934 | 84,152 | - | 302,284 | |||||||||||||||
| EBITDA | 41,466 | 91,155 | 30,872 | (20,287 | ) | 143,206 | ||||||||||||||
| Expense related to plant closure (Cost of sales) | 1,124 | - | - | - | 1,124 | |||||||||||||||
| Gain related to plant closure (SG&A) | 247 | - | - | - | 247 | |||||||||||||||
| Amortization of step-up for purchase price adjustments on inventory and accounts receivable | 7,276 | 1,428 | 302 | - | 9,006 | |||||||||||||||
| Transaction and advisory fees | 1,397 | 177 | 50 | 6,558 | 8,182 | |||||||||||||||
| Restructuring charges | 8,155 | 34 | 26 | 1,992 | 10,207 | |||||||||||||||
| Adjusted EBITDA | $ | 59,665 | $ | 92,794 | $ | 31,250 | $ | (11,737 | ) | $ | 171,972 | |||||||||
| Adjusted EBITDA Margin % | 9.7 | % | 19.4 | % | 11.0 | % | 12.8 | % | ||||||||||||
| (1) Includes stock-based compensation expense for the three and nine months ended July 31 2026 of | ||||||||||||||||||||
| QUANEX BUILDING PRODUCTS CORPORATION SALES ANALYSIS (In thousands) (Unaudited) | ||||||||||||||||
| Three Months Ended July 31, | Nine Months Ended July 31, | |||||||||||||||
| 2026 | 2025 | 2026 | 2025 | |||||||||||||
| Hardware Solutions:(1) | ||||||||||||||||
| Window and door hardware | $ | 133,038 | $ | 148,303 | $ | 387,047 | $ | 405,497 | ||||||||
| Screens | 85,830 | 76,809 | 219,980 | 203,269 | ||||||||||||
| Other | 2,055 | 2,004 | 6,027 | 6,025 | ||||||||||||
| $ | 220,923 | $ | 227,116 | $ | 613,054 | $ | 614,791 | |||||||||
| Extruded Solutions:(2) | ||||||||||||||||
| Window profiles | $ | 75,684 | $ | 76,775 | $ | 206,581 | $ | 206,629 | ||||||||
| Seals and gaskets | 20,241 | 20,415 | 57,405 | 57,857 | ||||||||||||
| Spacers | 59,996 | 55,201 | 160,124 | 148,733 | ||||||||||||
| Solar | 5,375 | 5,250 | 15,292 | 17,835 | ||||||||||||
| Flashing Tape | 2,821 | 3,038 | 7,567 | 6,751 | ||||||||||||
| Window and door hardware | 10,079 | 10,676 | 26,061 | 31,311 | ||||||||||||
| Other | 5,095 | 3,072 | 11,010 | 8,908 | ||||||||||||
| $ | 179,291 | $ | 174,427 | $ | 484,040 | $ | 478,024 | |||||||||
| Custom Solutions:(3) | ||||||||||||||||
| Wood solutions | $ | 59,282 | $ | 53,409 | $ | 162,841 | $ | 148,456 | ||||||||
| Access solutions | 29,483 | 27,370 | 78,984 | 74,158 | ||||||||||||
| Mixing solutions | 22,242 | 21,485 | 62,237 | 62,195 | ||||||||||||
| $ | 111,007 | $ | 102,264 | $ | 304,062 | $ | 284,809 | |||||||||
| Unallocated Corporate & Other: | ||||||||||||||||
| Eliminations | $ | (9,376 | ) | $ | (8,534 | ) | $ | (27,855 | ) | $ | (29,829 | ) | ||||
| $ | (9,376 | ) | $ | (8,534 | ) | $ | (27,855 | ) | $ | (29,829 | ) | |||||
| Net Sales | $ | 501,845 | $ | 495,273 | $ | 1,373,301 | $ | 1,347,795 | ||||||||
| (1) Reflects an unfavorable | ||||||||||||||||
| (2) Reflects an unfavorable | ||||||||||||||||
| (3) Reflects no impact and favorable | ||||||||||||||||
FAQ
How did Quanex (NX) perform financially in the third quarter of 2026?
For Q3 2026, Quanex reported net sales of $501.8 million and diluted EPS of $0.58. Net income was $26.5 million, versus a loss in the prior year period, and adjusted net income rose to $36.0 million, with adjusted diluted EPS of $0.79.
How did Quanex’s Q3 2026 results compare to the same quarter in 2025 for NX?
Compared with Q3 2025, net sales increased 1.3% to $501.8 million, gross margin improved to 28.2% from 27.9%, and operating income rose to $46.5 million from a prior-year loss affected by a goodwill impairment. Adjusted diluted EPS increased to $0.79 from $0.69.
What were the segment sales trends for Quanex (NX) in Q3 2026?
In Q3 2026, Hardware Solutions net sales fell 2.7% due to lower volumes and tariff reimbursements. Extruded Solutions net sales grew 2.8%, as pricing offset lower volumes, and the Custom Solutions segment grew 8.5%, driven by higher volume and improved pricing.
What cash flow and free cash flow did Quanex (NX) generate in Q3 2026?
Quanex generated $58.6 million of cash provided by operating activities in Q3 2026 and reported free cash flow of $47.8 million, up from $46.2 million in the same quarter of 2025, based on its definition of free cash flow.
What is Quanex’s debt and leverage position as of July 31, 2026 for NX?
As of July 31, 2026, Quanex had total debt of $672.2 million. The Company reported a Net Debt to last twelve months (LTM) Adjusted EBITDA leverage ratio of 2.8x and highlighted repayment of $42.25 million of debt during the third quarter.
How much liquidity does Quanex (NX) have and how did it change in Q3 2026?
Quanex reported liquidity of $363.1 million as of July 31, 2026, consisting of cash on hand plus revolver availability less letters of credit. This represented an increase of 10.5% compared to the prior period referenced.